Verrill's Health Care Industry Group is an interdisciplinary team of attorneys with decades of health care industry experience. We provide a full spectrum of legal services to the varied organizations and individual professionals in the increasingly complex health care industry, where organizations face emerging technologies, a broader than ever range of business issues, and intense government oversight. Through multidisciplinary collaboration, this group addresses the myriad issues and needs of companies in the heavily regulated, rapidly evolving health care industry.

General Health Care

  • Medicare/Medicaid and Third-Party Reimbursement
  • Mergers and Acquisitions
  • Academic and Biomedical Research
  • Regulatory Compliance and Contract Negotiations
  • e-Health and Health Information Technology
  • HIPAA/HITECH Privacy and Security
  • Accountable Care Organizations and Managed Care
  • Medical Staff and Patient Care
  • Licensure, Certification, and Accreditation
  • Physician Contracting and Compensation
  • Life Sciences

Corporate and Finance

  • Mergers and Acquisitions
  • Commercial Loan Transactions
  • Governance Issues

Employee Benefits

  • Employee Benefits, Executive Compensation, and Benefit Pension Plans
  • Fiduciary Compliance

Intellectual Property

  • Patent, Trademark, and Copyright Protection
  • Licensing and IP Contracts
  • Medical Product Marketing and Distribution Advice
  • Regulatory Compliance and Contract Negotiations
  • e-Health and Health Information Technology

Employment & Labor

  • Litigation Defense
  • ADA/Workers' Compensation/OSHA
  • Employee Relations and Privacy
  • Wage and Hour Laws
  • Labor-Management Relations
  • Union Campaigns and Litigation

Litigation

  • Medical Negligence
  • Licensing Board Complaints
  • White Collar Defense
  • Reimbursement Reviews
  • Risk Management
  • Regulatory Appeals (Federal and State, and Court Appeals of Final Agency Action)

Real Estate

  • Purchase and Sale Agreements and Options
  • Leases, Licenses, and Related Documents
  • Condominium and Related Documents
  • Loan Agreements and Financing
  • Due Diligence (e.g., Title Insurance, Survey, Zoning)
  • Construction Contracts
  • Land Use Permits and Approval

Firm Highlights

Publication/Podcast

“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments

Publication/Podcast

News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs

What happened? On August 19, 2020, the U.S. Department of Health and Human Services (“HHS”) issued a single paragraph statement rescinding U.S. Food and Drug Administration (“FDA”) guidance documents concerning premarket review of Laboratory...

Publication/Podcast

Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...

Publication/Podcast

Should Health Care Employers Prepare for COVID-19 As A Work-Related Injury?

While we know that everyone is being bombarded with COVID-19 recommendations, advice, news, and data, another important issue to manage in the workplace is the possibility of COVID-19 infection, if acquired at work and...

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

News

Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a...

Publication/Podcast

Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors

In November 2020, Alicia Siani co-authored with C. James Watson, James D. Whitledge, and Michele M. Burns "Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors," published in Journal of Medical...

Contact Verrill at (855) 307 0700